Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China / 中华预防医学杂志
Zhonghua Yu Fang Yi Xue Za Zhi
; (12): 103-107, 2022.
Article
em Zh
| WPRIM
| ID: wpr-929575
Biblioteca responsável:
WPRO
ABSTRACT
Influenza is an infectious respiratory disease caused by the influenza viruses. Older people, infants and people with underlying medical conditions could have a higher risk of severe influenza symptoms and complications. The co-infection of Coronavirus Diseases 2019 (COVID-19) with influenza viruses could lead to the complication of prevention, diagnosis, control, treatment, and recovery of COVID-19. Influenza vaccine and COVID-19 vaccine overlapped in target populations, vaccination time, and inoculation units. Although there was insufficient evidence on the immunogenicity and safety of co-administration of influenza vaccine and COVID-19 vaccine, World Health Organization and some countries recommended co-administration of inactivated influenza vaccine and COVID-19 vaccine. This review summarized domestic and international vaccination policies and research progress, and put forward corresponding suggestions in order to provide scientific support for the formulation of vaccination strategy on seasonal influenza vaccine and COVID-19 vaccine.
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Estações do Ano
/
Vacinas contra Influenza
/
China
/
Vacinação
/
Influenza Humana
/
Pandemias
/
Vacinas contra COVID-19
/
SARS-CoV-2
/
COVID-19
Limite:
Aged
/
Humans
/
Infant
País/Região como assunto:
Asia
Idioma:
Zh
Revista:
Zhonghua Yu Fang Yi Xue Za Zhi
Ano de publicação:
2022
Tipo de documento:
Article